The Sucampo Group

The Sucampo Group is an international affiliation of companies dedicated to rapidly and cost-effectively bringing proprietary pharmaceutical products to the global market.

Three operating companies belong to the Sucampo Group:

• Sucampo Pharmaceuticals, Inc., in the United States;
• Sucampo Pharma Europe Ltd in the United Kingdom; and
• Sucampo Pharma Ltd in Japan

These companies hold, collectively, an exclusive worldwide license from Sucampo AG to develop and commercialize AMITIZA® and other prostone compounds covered by patents and patent applications held by Sucampo AG.